I have 2000 shares and went from 4 k plus down to 0.
In my opinion an exaggeration because the data itself sounds good ... Good efficacy and no side effects apparent which also makes Pfizer confident... The fact that too few cases were reached in the study delays the whole thing at most, as you say, but that doesn't change the basic benefit of the vaccine
3
profile image
@Annonymous stop loss limit would have helped
This only works very irregularly for me at Trade Republic, as I recently had modest experiences with